|
|
|
Volumn 53, Issue 3, 2004, Pages 1127-1154
|
|
Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ZIDOVUDINE;
AFRICA;
ARTICLE;
BELMONT REPORT;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
DEVELOPING COUNTRY;
DISEASE TRANSMISSION;
ECONOMICS;
ETHICS;
HUMAN;
HUMAN EXPERIMENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTERNATIONAL COOPERATION;
MEDICAL ETHICS;
RISK ASSESSMENT;
SOCIAL JUSTICE;
UNITED STATES;
BELMONT REPORT;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
AFRICA;
AIDS VACCINES;
CLINICAL TRIALS;
DEVELOPING COUNTRIES;
DISEASE TRANSMISSION, VERTICAL;
HELSINKI DECLARATION;
HIV INFECTIONS;
HUMAN EXPERIMENTATION;
HUMANS;
INTERNATIONAL COOPERATION;
RISK ASSESSMENT;
SOCIAL JUSTICE;
UNITED STATES;
ZIDOVUDINE;
|
|
EID: 27744599406
PISSN: 00117188
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
